FDA Admits Pfizer Risk for Males Under 40

The FDA said more study is needed on the biggest risk highlighted by them to date of the Pfizer BioNTech Covid-19 vaccine, the only shot approved by them to date. Some males under 40 have been experiencing myocarditis and pericarditis, and even been hospitalized in critical care, according to the agency.
See the info contained on the FDA’s own website (shown in video).